Search in:

Advanced search

Expert Opinion on Therapeutic Patents Volume 17, 2007 - Issue 11

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Patent Evaluation

Combinations of a long-acting β₂ agonist; is it BI-1744-CL?

Boehringer Ingelheim: WO2007042467 and WO2007042468

Peter Norman Norman Consulting, 18 Pink Lane, Burnham, Buckinghamshire, SL1 8JW, UK [email protected]

Pages 1401-1404 | Published online: 09 Nov 2007

Cite this article
https://doi.org/10.1517/13543776.17.11.1401

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

LOTVALL J: Pharmacological similarities and differences between β2-agonists. Respir. Med. (2001) 95(Suppl. B):S7-S11.
PubMed Web of Science ®Google Scholar
JOHNSON M: Salmeterol. Med. Res. Rev. (1995) 15:225-257.
PubMed Web of Science ®Google Scholar
GREEN SA, SPASOFF AP, COLEMAN RA et al.: Sustained activation of a G protein-coupled receptor via “anchored” agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J. Biol. Chem. (1996) 271:24029-24035.
PubMed Web of Science ®Google Scholar
CURRIE GP: Indacaterol Novartis/SkyePharma. Curr. Opin. Investig. Drugs (2006) 7:457-463.
PubMed Web of Science ®Google Scholar
NORMAN P: Long acting β2agonists; Pfizer's development candidate? Expert Opin. Ther. Patents (2006) 16(1):1753-1757.
Web of Science ®Google Scholar

Patents

BOEHRINGER INGELHEIM INTERNATIONAL GMBH: WO2005070908 (2005).
Google Scholar
BOEHRINGER INGELHEIM INTERNATIONAL GMBH: WO2005077361 (2005).
Google Scholar
BOEHRINGER INGELHEIM INTERNATIONAL GMBH: WO2005102350 (2005).
Google Scholar
BOEHRINGER INGELHEIM INTERNATIONAL GMBH: US20050256115 (2005).
Google Scholar
BOEHRINGER INGELHEIM INTERNATIONAL GMBH: WO2005111005 (2005).
Google Scholar

Websites

http://www.clinicaltrials.gov/ct/show/NCT00468975?order=1 Clinical trial NCT00468975.
Google Scholar
http://www.clinicaltrials.gov/ct/show/NCT00452400?order=1 Clinical trial NCT00452400.
Google Scholar
http://www.centerwatch.com/patient/studies/stu115735.html Trial information: randomised, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of 4 weeks of once daily treatment of orally inhaled BI 1744 CL (2 μg, 5 μg, 10 μg, 20 μg) delivered by the Respimat® inhaler in patients with COPD.
Google Scholar
http://www.boehringer-ingelheim.com/corporate/asp/news/ndetail.asp?ID=4777 Press release (25 July 2007).
Google Scholar
http://www.clinicaltrials.gov/ct/show/NCT00467740?order=1 Clinical trial NCT00467740.
Google Scholar
http://www.clinicaltrials.gov/ct/show/NCT00358488?order=1 Clinical trial NCT00358488.
Google Scholar
http://www.clinicaltrials.gov/ct/show/NCT00463567?order=1 Clinical trial NCT00463567.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Combinations of a long-acting β₂ agonist; is it BI-1744-CL?

Boehringer Ingelheim: WO2007042467 and WO2007042468

Bibliography

Patents

Websites

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combinations of a long-acting β2 agonist; is it BI-1744-CL?

Boehringer Ingelheim: WO2007042467 and WO2007042468

Bibliography

Patents

Websites

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Combinations of a long-acting β₂ agonist; is it BI-1744-CL?